PAIYY (Aesthetic Medical International Holdings Group) Long-Term Debt: $2.2 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aesthetic Medical International Holdings Group Long-Term Debt?

Aesthetic Medical International Holdings Group PAIYY Long-Term Debt is $2.2 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Aesthetic Medical International Holdings Group's Long-Term Debt for the quarter that ended in Dec. 2025 was $2.2 Mil.

Aesthetic Medical International Holdings Group's quarterly Long-Term Debt declined from Dec. 2024 ($1.9 Mil) to Jun. 2025 ($0.5 Mil) but then increased from Jun. 2025 ($0.5 Mil) to Dec. 2025 ($2.2 Mil).

Aesthetic Medical International Holdings Group's annual Long-Term Debt declined from Dec. 2023 ($4.4 Mil) to Dec. 2024 ($1.9 Mil) but then increased from Dec. 2024 ($1.9 Mil) to Dec. 2025 ($2.2 Mil).

Aesthetic Medical International Holdings Group  (OTCPK:PAIYY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Aesthetic Medical International Holdings Group Long-Term Debt Related Terms

Aesthetic Medical International Holdings Group Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Aesthetic Medical International Holdings Group's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aesthetic Medical International Holdings Group Long-Term Debt Chart

Aesthetic Medical International Holdings Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.16 4.18 4.40 1.89 2.15

Aesthetic Medical International Holdings Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.40 4.24 1.89 0.49 2.15
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $2.2 Mil mean?
Aesthetic Medical International Holdings Group (PAIYY) has a Long-Term Debt of $2.2 Mil as of Dec. 2025.
Is Aesthetic Medical International Holdings Group's Long-Term Debt too high?
Aesthetic Medical International Holdings Group's current Long-Term Debt is $2.2 Mil.
How does Aesthetic Medical International Holdings Group's Long-Term Debt compare to GRST and BACK?
Aesthetic Medical International Holdings Group's Long-Term Debt of $2.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Aesthetic Medical International Holdings Group's current Long-Term Debt is $2.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aesthetic Medical International Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Aesthetic Medical International Holdings Group (PAIYY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.27, compared to a current price of $0.01 — trading 94.6% below its estimated fair value. The current Long-Term Debt is $2.2 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Aesthetic Medical International Holdings Group (PAIYY), the current Long-Term Debt is $2.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aesthetic Medical International Holdings Group Business Description

Address 1122 Nanshan Boulevard, Nanshan District, Guangdong Province, Shenzhen, CHN, 518052
Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from three service offerings: non-surgical aesthetic medical services, surgical aesthetic medical services, general healthcare services, and other aesthetic medical services in the People's Republic of China. The company derives a majority of its revenue from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.